ANTH
Anthera Pharmaceuticals, Inc.
ANTH
ANTH
Delisted
ANTH was delisted on the 27th of June, 2018.
40 hedge funds and large institutions have $4.81M invested in Anthera Pharmaceuticals, Inc. in 2017 Q2 according to their latest regulatory filings, with 6 funds opening new positions, 12 increasing their positions, 20 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
Holders
40
Holding in Top 10
–
Calls
$585K
Puts
–
Top Buyers
| 1 | +$604K | |
| 2 | +$234K | |
| 3 | +$70K | |
| 4 |
PP
Paloma Partners
Greenwich,
Connecticut
|
+$60K |
| 5 |
WS
Wedbush Securities
Los Angeles,
California
|
+$52.1K |
Top Sellers
| 1 | -$1.36M | |
| 2 | -$479K | |
| 3 | -$287K | |
| 4 |
SCM
Sio Capital Management
New York
|
-$142K |
| 5 |
SG Americas Securities
New York
|
-$98K |